247 related articles for article (PubMed ID: 22150672)
1. Transport mechanisms of flavanone aglycones across Caco-2 cell monolayers and artificial PAMPA membranes.
Kobayashi S; Nagai T; Konishi Y; Tanabe S; Morimoto K; Ogihara T
J Pharm Pharmacol; 2012 Jan; 64(1):52-60. PubMed ID: 22150672
[TBL] [Abstract][Full Text] [Related]
2. Transport evaluation of salicylic acid and structurally related compounds across Caco-2 cell monolayers and artificial PAMPA membranes.
Koljonen M; Rousu K; Cierny J; Kaukonen AM; Hirvonen J
Eur J Pharm Biopharm; 2008 Oct; 70(2):531-8. PubMed ID: 18582575
[TBL] [Abstract][Full Text] [Related]
3. Transepithelial transport of flavanone in intestinal Caco-2 cell monolayers.
Kobayashi S; Konishi Y
Biochem Biophys Res Commun; 2008 Mar; 368(1):23-9. PubMed ID: 18190788
[TBL] [Abstract][Full Text] [Related]
4. Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones.
Serra H; Mendes T; Bronze MR; Simplício AL
Bioorg Med Chem; 2008 Apr; 16(7):4009-18. PubMed ID: 18249545
[TBL] [Abstract][Full Text] [Related]
5. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
[TBL] [Abstract][Full Text] [Related]
6. The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
Tam KY; Avdeef A; Tsinman O; Sun N
J Med Chem; 2010 Jan; 53(1):392-401. PubMed ID: 19947605
[TBL] [Abstract][Full Text] [Related]
7. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
Akamatsu M; Fujikawa M; Nakao K; Shimizu R
Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
[TBL] [Abstract][Full Text] [Related]
8. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
[TBL] [Abstract][Full Text] [Related]
9. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
[TBL] [Abstract][Full Text] [Related]
10. Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.
Avdeef A; Artursson P; Neuhoff S; Lazorova L; Gråsjö J; Tavelin S
Eur J Pharm Sci; 2005 Mar; 24(4):333-49. PubMed ID: 15734300
[TBL] [Abstract][Full Text] [Related]
11. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum.
Berginc K; Zakelj S; Levstik L; Ursic D; Kristl A
Eur J Pharm Biopharm; 2007 May; 66(2):281-5. PubMed ID: 17129714
[TBL] [Abstract][Full Text] [Related]
12. pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers.
Neuhoff S; Ungell AL; Zamora I; Artursson P
Eur J Pharm Sci; 2005 Jun; 25(2-3):211-20. PubMed ID: 15911216
[TBL] [Abstract][Full Text] [Related]
13. QSAR study on permeability of hydrophobic compounds with artificial membranes.
Fujikawa M; Nakao K; Shimizu R; Akamatsu M
Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
[TBL] [Abstract][Full Text] [Related]
14. Quercetin and naringenin transport across human intestinal Caco-2 cells.
Nait Chabane M; Al Ahmad A; Peluso J; Muller CD; Ubeaud G
J Pharm Pharmacol; 2009 Nov; 61(11):1473-83. PubMed ID: 19903372
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa.
Miret S; Abrahamse L; de Groene EM
J Biomol Screen; 2004 Oct; 9(7):598-606. PubMed ID: 15475479
[TBL] [Abstract][Full Text] [Related]
16. Determination of the stereoselectivity of chiral drug transport across Caco-2 cell monolayers.
He Y; Zeng S
Chirality; 2006 Jan; 18(1):64-9. PubMed ID: 16287047
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
[TBL] [Abstract][Full Text] [Related]
18. Permeation prediction of M100240 using the parallel artificial membrane permeability assay.
Hwang KK; Martin NE; Jiang L; Zhu C
J Pharm Pharm Sci; 2003; 6(3):315-20. PubMed ID: 14738711
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of the naringin low uptake by intestinal Caco-2 cells.
Tourniaire F; Hassan M; André M; Ghiringhelli O; Alquier C; Amiot MJ
Mol Nutr Food Res; 2005 Oct; 49(10):957-62. PubMed ID: 16189799
[TBL] [Abstract][Full Text] [Related]
20. PAMPA--a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones.
Bermejo M; Avdeef A; Ruiz A; Nalda R; Ruell JA; Tsinman O; González I; Fernández C; Sánchez G; Garrigues TM; Merino V
Eur J Pharm Sci; 2004 Mar; 21(4):429-41. PubMed ID: 14998573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
